CD300LD and neoplasm: In tumor‐bearing mouse models, CD300ld knockout significantly reduces PMN‐MDSC infiltration into tumors, enhances the activation and migration of CD8+ T cells, and reshapes the immunosuppressive microenvironment into an antitumor state.